Items tagged with Pediatrics

Open letter to WHO: Recording and reporting of preventive TB therapy in children (post with simple image)

Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.

(post with simple image)

TB Alliance and partners announce world’s first availability of appropriate, child-friendly TB medicines in correct doses (post with simple image)

Medication simplifies and improves treatment for 1 million children with TB; Medicines come in dispersible fixed-dose combinations at the correct dosages, tablets no longer need to be cut or crushed; These products can improve adherence and child survival from TB.

Tuberculosis: opportunities and challenges for the 90–90–90 targets in HIV-infected children (post with simple image)

TB may be an important barrier to achievement of the 90–90–90 targets, but specific attention to TB care in HIV-infected children may provide important opportunities to enhance the care of both TB and HIV in children.

Sign a petition: Tell world leaders to end childhood tuberculosis (post with simple image)

The petition will be open for signatures until World TB Day, March 2016, when it will be presented to world leaders.

Handbook of Child and Adolescent Tuberculosis (post with simple image)

edited by Jeffrey R. Starke and Peter R. Donald

Advocates call for WHO to update Delamanid Guidance to include children (post with simple image)

On World TB Day, and in light of new evidence of safety in children, advocates called on the World Health Organization to update its 2014 guidance on delamanid to include children.

Rapid Clinical Advice on new TB drugs in children (post with simple image)

The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.

2016 i-Base/TAG Pipeline Report (post with simple image)

Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

“Towards Ending the Neglect?” DNDi releases update on its paediatric HIV programme (post with simple image)

As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).